This filing details the ownership of EURO TECH HOLDINGS CO LTD by LEUNG TAK CHUNG. Mr. Leung, who is a director, officer, and 10% owner, reported holding 3,999,347 ordinary shares directly following a transaction. The report was filed on April 10, 2026, with the period of report being March 18, 2026....

This filing reports initial ownership of securities by LEUNG YIN LUNG, who is an officer and director of EURO TECH HOLDINGS CO LTD. The filing indicates direct ownership of 2,500 ordinary shares. Additionally, it details holdings of stock options, including one with an exercise price of $1.04 expiring on April 18, 2029...

This filing is an Initial Statement of Beneficial Ownership (Form 3) for Wang Xu, CEO and Director of LakeShore Biopharma Co., Ltd. (LSB). Wang Xu has been granted share options to acquire 203,464 ordinary shares with an exercise price of $1.225 per share. The options vest starting December 31, 2024, with 25% vesting o...

This filing reports the initial beneficial ownership of securities for Hui David Shao, President and CBO of LakeShore Biopharma Co., Ltd. The filing indicates direct ownership of 133,360 Ordinary Shares and indirect ownership of 180,278 Ordinary Shares through Mountainview Investment Holdings LLC. Hui David Shao serves...

This filing details the ownership of securities by John Lawler, Chief Development Officer of Chemomab Therapeutics Ltd. (CMMB). The filing, submitted on April 10, 2026, covers the period ending March 18, 2026. It includes information on both derivative and non-derivative holdings. Lawler directly owns various stock opt...

This filing is an initial statement of beneficial ownership for FBS Global Ltd (FBGL). The reporting owner, Lee Puay Khng, a director of the company, reported no securities owned as of March 18, 2026. The signature date was April 10, 2026....

This filing details changes in beneficial ownership for Borqs Technologies, Inc. (BRQSF). Ji (Richard) Li, identified as a director, reported a post-transaction ownership of 386,615 ordinary shares. The ownership is direct. The reporting owner, Li Ji (Richard), resides in Hong Kong. The filing date was April 10, 2026, ...

This document is a Form 3 filing, representing an Initial Statement of Beneficial Ownership of Securities, for Huadi International Group Co., Ltd. (HUDI). The reporting owner is Li Songlin, identified by CIK 0002128236. Li Songlin is a director at the company, as indicated by the reporting owner relationship details. T...

This filing reports the initial statement of beneficial ownership for Marcos Marcelo Mindlin, related to Loma Negra Compania Industrial Argentina Sociedad Anonima. The reporting owner is identified as a shareholder of Intercement. The filing indicates that following the transaction, Marcos Marcelo Mindlin directly owns...

This Form 3 filing reports that Ricardo Damian Luttini, the Chief Audit Executive of Edenor (EDN), has no securities ownership in the company as of March 18, 2026. The filing was signed on April 10, 2026, and indicates that Luttini holds no direct or indirect ownership of Edenor's securities. As a Form 3 filing, this r...

This filing is an Initial Statement of Beneficial Ownership (Form 3) for MA XIN, the Chief Financial Officer of Bon Natural Life Ltd. The report date is April 2, 2026. MA XIN is reporting beneficial ownership of securities in Bon Natural Life Ltd. The filing indicates that there are no securities owned by the reporting...

This is a Form 3 filing by Edward Francis Moynihan, President & CEO of Oliver Wyman (a Marsh & McLennan Companies subsidiary), reporting his initial beneficial ownership in Marsh & McLennan Companies, Inc. (ticker: MRSH). The filing discloses ownership of 9,121 shares of common stock and significant derivative holdings...

This filing is an Exhibit 24, a Power of Attorney granted by Makoto Samejima, Chief Financial Officer of Mizuho Financial Group, Inc., to Yuki Nishii and Yusuke Maruyama. This grants them the authority to execute and deliver forms required by the U.S. Securities and Exchange Commission related to Samejima's ownership o...

This filing details changes in beneficial ownership for Hideki Tsujimori, Chief Process Officer at MIZUHO FINANCIAL GROUP INC. The report includes transactions involving phantom stock units, which are convertible to common stock or cash. Specifically, 2,150 phantom stock units are noted, with settlement upon retirement...

This filing reports on behalf of Shuji Matsuura, an officer of MIZUHO FINANCIAL GROUP INC, regarding ownership of the company's securities. The filing details holdings of phantom stock units, which are vested and unvested, with settlement upon retirement or on scheduled dates in 2024, 2025, and 2026. These units repres...

This document is a Form 3 filing, an Initial Statement of Beneficial Ownership, for DR REDDYS LABORATORIES LTD (RDY). The reporting owner is MUNNIRPALLAM MADHU SUNDAR SUBRAMANIAN, identified by CIK 0002128817. Mr. Subramanian holds the position of Global Head of Quality and PV. The filing indicates direct ownership of ...

This is a Form 3 filing by Yasuko Maita, a director of LEIFRAS Co., Ltd. (ticker: LFS), disclosing her ownership status as of March 18, 2026. The filing indicates that Maita currently owns no securities in the company. She is identified as a director but not as an officer or 10% owner. The filing was signed on April 10...

This filing reports a change in beneficial ownership of securities for Peter Ashley Marks, a director at ALTERITY THERAPEUTICS LTD. The changes involve both derivative and non-derivative holdings. Specifically, there are listed options expiring on February 26, 2027, and unlisted options expiring on December 30, 2027. T...

This filing reports on behalf of Shuji Matsuura, an officer of MIZUHO FINANCIAL GROUP INC, regarding ownership of the company's securities. The filing details holdings of phantom stock units, which are vested and unvested, with settlement upon retirement or on scheduled dates in 2024, 2025, and 2026. These units repres...

This is a Form 3 filing for Paul Miele, Senior Vice President and Chief Commercial Officer of Accuray Incorporated (ticker: ARAY). The filing reports that as of April 6, 2026, Mr. Miele does not beneficially own any securities of the company. The document includes a power of attorney executed on April 6, 2026, authoriz...

This filing reports the initial statement of beneficial ownership for Marcos Marcelo Mindlin, related to Loma Negra Compania Industrial Argentina Sociedad Anonima. The reporting owner is identified as a shareholder of Intercement. The filing indicates that following the transaction, Marcos Marcelo Mindlin directly owns...

This filing is a Form 3, which reports initial beneficial ownership of securities, by George Adi Mor, Chief Executive Officer and Director of Chemomab Therapeutics Ltd. The filing details holdings of American Depositary Shares (ADS) both directly and indirectly, including those held by his spouse. It also outlines vari...

This Form 3 filing discloses the initial statement of beneficial ownership of securities by Alan Moses, a director of Chemomab Therapeutics Ltd. (CMMB). The filing reveals Moses holds six separate stock option grants to purchase American Depositary Shares, with exercise prices ranging from $2.14 to $109.04 per share. T...

This is a Form 3 filing by Edward Francis Moynihan, President & CEO of Oliver Wyman (a Marsh & McLennan Companies subsidiary), reporting his initial beneficial ownership in Marsh & McLennan Companies, Inc. (ticker: MRSH). The filing discloses ownership of 9,121 shares of common stock and significant derivative holdings...

This filing is an exhibit detailing a Power of Attorney granted by Martin Patrick Murphy, a director at Century Therapeutics, Inc. (IPSC). The document, dated December 9, 2025, and effective April 10, 2026, appoints Brent Pfeiffenberger, Douglas Carr, and Gregory Russotti as attorneys-in-fact. They are authorized to ex...